{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:35:59Z","timestamp":1791653759403,"version":"4.3.4"},"update-to":[{"DOI":"10.1371\/journal.ppat.1008157","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000}}],"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["CB3957"],"award-info":[{"award-number":["CB3957"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-14-C-0115"],"award-info":[{"award-number":["HDTRA1-14-C-0115"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1008157","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T19:13:50Z","timestamp":1575314030000},"page":"e1008157","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-8912","authenticated-orcid":true,"given":"Crystal W.","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery W.","family":"Froude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-9984","authenticated-orcid":true,"given":"Charles E.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-3260","authenticated-orcid":true,"given":"M. Louise","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Streatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Musiychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Kervinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Zeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidadi","family":"Yusibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-3734","authenticated-orcid":true,"given":"Pamela J.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"ppat.1008157.ref001","unstructured":"Medical Aspects of Biological Warfare. Joel Bozue CKC, Pamela J. Glass, editor: The Borden Institute, U.S. Army Medical Department Government Printing Office; 2018 August 1, 2018."},{"issue":"5","key":"ppat.1008157.ref002","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/AM.25.5.755-762.1973","article-title":"Resistance to arbovirus challenge in mice immediately after vaccination","volume":"25","author":"J Casals","year":"1973","journal-title":"Appl Microbiol"},{"issue":"10","key":"ppat.1008157.ref003","first-page":"1627","article-title":"Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study","volume":"39","author":"EF Baker","year":"1978","journal-title":"Am J Vet Res"},{"issue":"2","key":"ppat.1008157.ref004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.64.2.217","article-title":"Active Immunization of Guinea Pigs with the Virus of Equine Encephalomyelitis: Iii. Quantitative Studies of Serum Antiviral Bodies in Animals Immunized with Active and Inactive Virus","volume":"64","author":"HR Cox","year":"1936","journal-title":"J Exp Med"},{"issue":"2","key":"ppat.1008157.ref005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.74.2.115","article-title":"Influence of Age on Susceptibility and on Immune Response of Mice to Eastern Equine Encephalomyelitis Virus","volume":"74","author":"IM Morgan","year":"1941","journal-title":"J Exp Med"},{"issue":"4","key":"ppat.1008157.ref006","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.76.4.357","article-title":"Induced Resistance of the Central Nervous System to Experimental Infection with Equine Encephalomyelitis Virus: I. Neutralizing Antibody in the Central Nervous System in Relation to Cerebral Resistance","volume":"76","author":"IM Morgan","year":"1942","journal-title":"J Exp Med"},{"issue":"5","key":"ppat.1008157.ref007","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.4049\/jimmunol.110.5.1345","article-title":"Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. I. Passive transfer of protection with immune serum and immune cells","volume":"110","author":"SG Rabinowitz","year":"1973","journal-title":"J Immunol"},{"issue":"1","key":"ppat.1008157.ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2011.01.010","article-title":"A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus","volume":"90","author":"SA Goodchild","year":"2011","journal-title":"Antiviral research"},{"issue":"34","key":"ppat.1008157.ref009","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1016\/j.vaccine.2010.06.038","article-title":"A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus","volume":"28","author":"WG Hu","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"ppat.1008157.ref010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virol.2011.03.016","article-title":"Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection","volume":"414","author":"AR Hunt","year":"2011","journal-title":"Virology"},{"issue":"Pt 9","key":"ppat.1008157.ref011","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.81925-0","article-title":"A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus","volume":"87","author":"AR Hunt","year":"2006","journal-title":"J Gen Virol"},{"issue":"6","key":"ppat.1008157.ref012","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.129.6.2763","article-title":"Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies","volume":"129","author":"JH Mathews","year":"1982","journal-title":"J Immunol"},{"issue":"2","key":"ppat.1008157.ref013","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virol.2012.01.038","article-title":"A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge","volume":"426","author":"LM O\u2019Brien","year":"2012","journal-title":"Virology"},{"issue":"1\u20132","key":"ppat.1008157.ref014","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virusres.2006.02.003","article-title":"Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III","volume":"120","author":"RJ Phillpotts","year":"2006","journal-title":"Virus Res"},{"issue":"5","key":"ppat.1008157.ref015","doi-asserted-by":"crossref","first-page":"e37242","DOI":"10.1371\/journal.pone.0037242","article-title":"Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo","volume":"7","author":"T Rulker","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ppat.1008157.ref016","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0042-6822(85)90343-5","article-title":"The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes","volume":"142","author":"JT Roehrig","year":"1985","journal-title":"Virology"},{"issue":"11\u201312","key":"ppat.1008157.ref017","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","article-title":"Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus","volume":"20","author":"RJ Phillpotts","year":"2002","journal-title":"Vaccine"},{"issue":"46","key":"ppat.1008157.ref018","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1016\/j.vaccine.2010.09.005","article-title":"Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates","volume":"28","author":"LC Dupuy","year":"2010","journal-title":"Vaccine"},{"issue":"20","key":"ppat.1008157.ref019","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1128\/JVI.01406-14","article-title":"Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses","volume":"88","author":"DS Reed","year":"2014","journal-title":"J Virol"},{"issue":"6","key":"ppat.1008157.ref020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.77.6.521","article-title":"Venezuelan Equine Encephalomyelitis in Man","volume":"77","author":"J Casals","year":"1943","journal-title":"J Exp Med"},{"issue":"17","key":"ppat.1008157.ref021","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.1943.02840520004002","article-title":"Human infection with Venezuelan equine encephalomyelitis virus: a report on eight cases of infection acquired in the laboratory","volume":"123","author":"EH Lennette","year":"1943","journal-title":"JAMA"},{"issue":"1","key":"ppat.1008157.ref022","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0042-6822(88)90659-9","article-title":"In vitro mechanisms of monoclonal antibody neutralization of alphaviruses","volume":"165","author":"JT Roehrig","year":"1988","journal-title":"Virology"},{"issue":"2","key":"ppat.1008157.ref023","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4049\/jimmunol.177.2.1129","article-title":"Modulation of the effector functions of a human IgG1 through engineering of its hinge region","volume":"177","author":"WF Dall\u2019Acqua","year":"2006","journal-title":"Journal of immunology"},{"issue":"9","key":"ppat.1008157.ref024","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.4049\/jimmunol.169.9.5171","article-title":"Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences","volume":"169","author":"WF Dall\u2019Acqua","year":"2002","journal-title":"Journal of immunology"},{"issue":"5","key":"ppat.1008157.ref025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4161\/mabs.3.5.16983","article-title":"Neonatal Fc receptor and IgG-based therapeutics","volume":"3","author":"TT Kuo","year":"2011","journal-title":"MAbs"},{"issue":"2","key":"ppat.1008157.ref026","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0042-6822(90)90533-W","article-title":"Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein","volume":"177","author":"BJ Johnson","year":"1990","journal-title":"Virology"},{"key":"ppat.1008157.ref027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev.me.25.020174.000301","article-title":"Venezuelan equine encephalitis virus infection in man","volume":"25","author":"NJ Ehrenkranz","year":"1974","journal-title":"Annu Rev Med"},{"issue":"2","key":"ppat.1008157.ref028","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4269\/ajtmh.1979.28.329","article-title":"Ten clinical cases of human infection with venezuelan equine encephalomyelitis virus, subtype I-D","volume":"28","author":"WH Dietz","year":"1979","journal-title":"Am J Trop Med Hyg"},{"key":"ppat.1008157.ref029","first-page":"145","article-title":"Encefalitis Equina Venezolana. Estudio Clinico Y De Laboratorio en Pacientes Pediatricos","volume":"14","author":"DG de Pellacani","year":"1973","journal-title":"Invest Clin"},{"issue":"3 Pt 1","key":"ppat.1008157.ref030","first-page":"531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group","volume":"102","year":"1998","journal-title":"Pediatrics"},{"issue":"388","key":"ppat.1008157.ref031","article-title":"A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants","volume":"9","author":"Q Zhu","year":"2017","journal-title":"Science translational medicine"},{"key":"ppat.1008157.ref032","article-title":"Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza","author":"SO Ali","year":"2018","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"10","key":"ppat.1008157.ref033","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.celrep.2018.08.009","article-title":"Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop","volume":"24","author":"CD Murin","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"ppat.1008157.ref034","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00456-16","article-title":"Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae","volume":"24","author":"E Diago-Navarro","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"ppat.1008157.ref035","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/AAC.02295-13","article-title":"Efficacy and safety of AVP-21D9, an anthrax monoclonal antibody, in animal models and humans","volume":"58","author":"NV Malkevich","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"6","key":"ppat.1008157.ref036","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cpdd.410","article-title":"Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans","volume":"7","author":"CF Nagy","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"5","key":"ppat.1008157.ref037","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00030-11","article-title":"A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates","volume":"18","author":"LC Dupuy","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"18","key":"ppat.1008157.ref038","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.vaccine.2010.02.056","article-title":"Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus","volume":"28","author":"SS Martin","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"ppat.1008157.ref039","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.vaccine.2009.10.126","article-title":"Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB","volume":"28","author":"SS Martin","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"ppat.1008157.ref040","doi-asserted-by":"crossref","DOI":"10.3390\/v10040147","article-title":"Human-Like Neutralizing Antibodies Protect Mice from Aerosol Exposure with Western Equine Encephalitis Virus","volume":"10","author":"CW Burke","year":"2018","journal-title":"Viruses"},{"issue":"5861","key":"ppat.1008157.ref041","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"AL Schmaljohn","year":"1982","journal-title":"Nature"},{"issue":"4","key":"ppat.1008157.ref042","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/v4040447","article-title":"Structural basis for differential neutralization of ebolaviruses","volume":"4","author":"S Bale","year":"2012","journal-title":"Viruses"},{"issue":"24","key":"ppat.1008157.ref043","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"DS Reed","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"ppat.1008157.ref044","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/19420862.2017.1409320","article-title":"Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system","volume":"10","author":"G Thom","year":"2018","journal-title":"MAbs"},{"issue":"Pt 12","key":"ppat.1008157.ref045","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1099\/0022-1317-69-12-3005","article-title":"Recombinant vaccinia\/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins","volume":"69","author":"RM Kinney","year":"1988","journal-title":"J Gen Virol"},{"issue":"12","key":"ppat.1008157.ref046","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.celrep.2015.08.038","article-title":"Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail","volume":"12","author":"JR Kugelman","year":"2015","journal-title":"Cell reports"},{"issue":"21","key":"ppat.1008157.ref047","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1128\/JVI.01381-14","article-title":"Epitope mapping of the hemagglutinin molecule of A\/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants","volume":"88","author":"Y Matsuzaki","year":"2014","journal-title":"Journal of virology"},{"issue":"2","key":"ppat.1008157.ref048","first-page":"344","article-title":"Monoclonal antibody-escape variant of dengue virus serotype 1: Genetic composition and envelope protein expression","volume":"32","author":"YK Chem","year":"2015","journal-title":"Trop Biomed"},{"issue":"15","key":"ppat.1008157.ref049","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1128\/JVI.01032-14","article-title":"Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes","volume":"88","author":"P Pal","year":"2014","journal-title":"Journal of virology"},{"issue":"12","key":"ppat.1008157.ref050","doi-asserted-by":"crossref","first-page":"e1002390","DOI":"10.1371\/journal.ppat.1002390","article-title":"Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants","volume":"7","author":"CY Lee","year":"2011","journal-title":"PLoS pathogens"},{"issue":"3","key":"ppat.1008157.ref051","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.coviro.2012.02.014","article-title":"Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectives","volume":"2","author":"LC Dupuy","year":"2012","journal-title":"Current opinion in virology"},{"issue":"2568","key":"ppat.1008157.ref052","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1126\/science.99.2568.225","article-title":"Fatal Encephalitis in Man Due to the Venezuelan Virus of Equine Encephalomyelitis in Trinidad","volume":"99","author":"R Randall","year":"1944","journal-title":"Science"},{"issue":"6719","key":"ppat.1008157.ref053","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"JN Matthews","year":"1990","journal-title":"BMJ"},{"key":"ppat.1008157.ref054","first-page":"819","volume-title":"Nonparametric statistical methods","author":"M Hollander","year":"2014"},{"key":"ppat.1008157.ref055","volume-title":"Nondetects and data analysis: statistics for censored environmental data","author":"DR Helsel","year":"2005"},{"key":"ppat.1008157.ref056","doi-asserted-by":"crossref","DOI":"10.1002\/0470114754","volume-title":"An introduction to categorical data analysis","author":"A Agresti","year":"2007"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1008157","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T15:17:46Z","timestamp":1695482266000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008157"}},"subtitle":[],"editor":[{"given":"Mehul","family":"Suthar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008157","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1008157","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]}}}